Minerva urology and nephrologyHumansUrinary Bladder NeoplasmsBCG VaccineRetrospective StudiesFemale
Exploring the influence of the bladder microbiome on BCG immunotherapy outcomes for high-risk non muscle invasive bladder cancer.
Gabriele Tulone, Nicola Pavan, Teresa M Fasciana, Anna Martorana, Cristina Minasola, Maria R Tricoli, Francesco Claps, Laiba Mariyam, Dalila Marmo, Nicola Serra, Anna Giammanco, Alchiede Simonato
Published: 202510.23736/S2724-6051.25.06431-6
Abstract
BACKGROUND: Intravesical Bacillus Calmette-Guérin (BCG) is an established adjuvant therapy for high-risk superficial bladder cancer, though its efficacy varies among patients. Recent interest in the urinary microbiome comprising microorganisms inhabi…
Preview only. Read the full abstract at the source